An (1)H-MRS evaluation of the phosphocreatine/creatine pool (tCr) in human muscle.
The human gastrocnemius was examined with and without creatine supplementation under the conditions of rest, ischemic fatigue (IF), and recovery to perturb the pool sizes and equilibrium between phosphocreatine (PCr) and creatine (Cr). (1)H- and (31)P-magnetic resonance spectroscopy (MRS) were used to examine the total creatine (tCr) pool in each of the metabolic states. (31)P-MRS monitored the depletion of the PCr peak during IF to <5% of that at rest. (1)H-MRS focused on the tCr methyl peak at 3.02 ppm (dipolar coupled triplet), at which point it was expected that the triplet peak intensity would be similar both in IF and rest. Initial (1)H-MRS data showed the peak intensity during IF decreased, suggesting a change in tCr pool size. Subsequent studies of transverse relaxation time (T(2)) revealed that this decline was primarily due to a more rapid T(2) decay of the tCr peak in IF (T(2) approximately 40 ms) compared with at rest (T(2) approximately 162 ms). Because Cr is the major contributor to tCr in IF, it is possible that there is a pool of Cr displaying reduced mobility in vivo. Moreover, the residual dipolar coupled triplet observed at rest collapsed into a broad singlet during IF, suggestive of significant changes in the ordered environment experienced at rest for PCr compared with when it is converted to Cr during IF. In addition, these data suggest that in (1)H-MRS studies whose goals include quantitative estimates of tCr pool sizes, standardized metabolic conditions or careful T(2) evaluations will be required.
Trump
M E
ME
Department of Zoology, University of British Columbia, Vancouver, British Columbia V6T-1Z4.
Hanstock
C C
CC
Allen
P S
PS
Gheorghiu
D
D
Hochachka
P W
PW
D003401:Creatine / Q000008:administration & dosage* / Q000032:analysis*; D019587:Dietary Supplements; D015444:Exercise / Q000502:physiology; D006801:Humans; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy; D018763:Muscle Fatigue / Q000502:physiology; D018482:Muscle, Skeletal / Q000737:chemistry*; D010725:Phosphocreatine / Q000032:analysis*; D010807:Physical Endurance; D010919:Placebos; D012146:Rest
D010919:Placebos; D010725:Phosphocreatine; D003401:Creatine